Using our integrated multi-omics, we discovered a crosstalk network of GPX4 in pan-cancers, providing mechanistic support for developing broad-spectrum therapies - a key advancement beyond the descriptive findings in recent reviews. The gene discussed is GPX4; the disease is cancer.